Related Experiment Video
Updated: Jun 25, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Tumor cells impair immunological synapse formation via central nervous system-enriched metabolite
Yihong Li1, Min Huang1, Minger Wang2
1Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
Abstract:
Tumors employ various strategies to evade immune surveillance. Central nervous system (CNS) has multiple features to restrain immune response. Whether tumors and CNS share similar programs of immunosuppression is elusive. Here, we analyze multi-omics data of tumors from HER2+ breast cancer patients receiving trastuzumab and anti-PD-L1 antibody and find that CNS-enriched N-acetyltransferase 8-like (NAT8L) and its metabolite N-acetylaspartate (NAA) are overexpressed in resistant tumors. In CNS, NAA is released during brain inflammation. NAT8L attenuates brain inflammation and impairs anti-tumor immunity by inhibiting cytotoxicity of natural killer (NK) cells and CD8+ T cells via NAA. NAA disrupts the formation of immunological synapse by promoting PCAF-induced acetylation of lamin A-K542, which inhibits the integration between lamin A and SUN2 and impairs polarization of lytic granules. We uncover that tumor cells mimic the anti-inflammatory mechanism of CNS to evade anti-tumor immunity and NAT8L is a potential target to enhance efficacy of anti-cancer agents.
Insights
Tumors evade immune surveillance by mimicking the central nervous system (CNS). Overexpressed N-acetyltransferase 8-like (NAT8L) and its metabolite N-acetylaspartate (NAA) impair anti-tumor immunity by inhibiting natural killer (NK) and CD8+ T cells.
Area of Science:
- Immunology
- Neuroscience
- Oncology
Background:
- Tumors utilize immune evasion strategies.
- The central nervous system (CNS) possesses inherent immune-restraining features.
- It remains unclear if tumors and the CNS share immunosuppressive mechanisms.
Purpose of the Study:
- To investigate whether tumors share immunosuppressive programs with the CNS.
- To identify molecular mechanisms by which tumors evade immune surveillance.
Main Methods:
- Multi-omics data analysis of HER2+ breast cancer patient tumors treated with trastuzumab and anti-PD-L1.
- Investigated the role of N-acetyltransferase 8-like (NAT8L) and N-acetylaspartate (NAA) in tumor immunosuppression.
Main Results:
- CNS-enriched NAT8L and its metabolite NAA were overexpressed in resistant tumors.
- NAA impairs anti-tumor immunity by inhibiting natural killer (NK) and CD8+ T cell cytotoxicity.
- NAA disrupts immunological synapse formation by affecting lamin A acetylation, inhibiting lytic granule polarization.
Conclusions:
- Tumor cells mimic CNS anti-inflammatory mechanisms to evade anti-tumor immunity.
- NAT8L is a potential therapeutic target to enhance anti-cancer agent efficacy.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

